Arq - The Hyper Intelligent Investment Engine By Angel Broking

Outcome of board meeting of Rekvina Laboratories

Rekvina Laboratories has announced that the Board of Directors of the Company at its meeting held on 24 March 2014, inter alia, has approved sub-division of face value of equity shares. Every shareholder holding 1 (one) equity share of Rs 10 each will be entitled to 2 (two) equity share of Rs 5 each. The extraordinary general meeting of the Company will be held on 16 April 2014 to obtain necessary approvals from the members.

Powered by Capital Market - Live News